European Archives - Page 891 of 980 - European Medical Journal

EMJ

Drinking the EU Economy Dry: Experts Call for Action on the Crippling Socio-Economic Costs of Alcohol

November 12, 2015: Europe is the heaviest drinking region of the world, with consumption levels in some countries approximately twice the global average.

EMJ

Revolutionary Computer Program Diagnoses Cancer in 2 Days

NOVEL diagnostic technology based on advanced self-learning computer algorithms may identify the source of cancer in a patient with 85% certainty…

EMJ

Self-Propelled Microparticles Designed to Stop Bleeding

FIRST self-propelled particles capable of delivering coagulants against the flow of blood have been developed to treat severe bleeding…

EMJ Dermatology 3.1 2015

Hello and a very warm welcome to European Medical Journal Dermatology. This edition of our eJournal is the last for this eventful year, and so we have…

EMJ

New German Data Show the Use of Endocuff Vision® May Improve Adenoma Detection Rates and Reduce Health System Costs

London, Wednesday 11 November 2015, 07:00 GMT: Norgine B.V. today announced new data showing that ENDOCUFF VISION®, a colonoscope device…

EMJ

Sherlock Holmes and the Assessment of Premature MI

At the 2015 ESC congress in London UK, Aegerion Pharmaceuticals organized a satellite symposium in which three expert witnesses were cross examined on…

Intelligent Application of Breast Cancer Trials Data in the Clinic

This meeting commenced with a talk from Prof Loibl on neoadjuvant and adjuvant strategies for HER2positive (human epidermal growth factor receptor…)

Incorporating PARP Inhibition in Cancer Therapy: Key Questions, Expert Answers

This engaging symposium focussed on the rationale and current evidence supporting the role for poly(adenosine diphosphate-ribose) polymerase (PARP)…

Cabozantinib Versus Everolimus in Patients with Advanced Renal Cell Carcinoma: Results of a Randomised Phase III Trial (METEOR)

The METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma (RCC) was reported by Prof Choueiri at the European Cancer Congress…

Current and Future Developments in the Treatment of CD30+ Lymphomas

CD30 is a cell membrane protein expressed on the surface of a range of lymphomas, which has important diagnostic, pathogenic, and prognostic roles.